Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Lacosamide Tablets

CGMP Deviations

Ongoing cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-679-60 D-0330-2025
Class II · Moderate risk

chlorproMAZINE Hydrochloride Tablets

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Ongoing Nitrosamine impurity Glenmark Pharmaceuticals Inc., USA NDC 68462-864-01 D-0309-2025

Recalls by year